Su Jung Park
Papers
1
Total Citations
3
H-Index
1
About
Dr. Su Jung Park is a leading clinical researcher in head and neck oncology, with a primary focus on optimizing multimodality treatment outcomes for human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinomas (OPSCCs). Her major contributions center on refining the critical timing and sequencing of surgery and adjuvant radiation therapy (RT) to improve patient prognosis. In her landmark multi-institutional cohort study, "Association Between Time From Surgery to Radiation Therapy and Multimodality Treatment Outcomes in HPV+ Head and Neck Cancer," Dr. Park rigorously examined the impact of the surgery-to-RT interval (TSRT) on treatment efficacy. Her work provides essential evidence supporting the National Comprehensive Cancer Network (NCCN) guideline recommending that RT commence within six weeks post-surgery to avoid compromising oncologic control. This research, already garnering citations shortly after its 2024 publication, underscores her influence in shaping evidence-based practice. Dr. Park’s dedication to advancing precision in treatment sequencing makes her a vital voice for clinicians and researchers striving to improve survival and quality of life for patients with HPV-positive head and neck cancers.
Research Focus
Key Achievements
Top Papers
- 1